Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial Evaluating JYP0035 Capsule Monotherapy in Patients With Advanced Solid Tumors
Sponsor: Chengdu JOYO pharma Co., Ltd.
Summary
The goal of this Phase I clinical trial is to evaluate the safety, tolerability, and pharmacokinetic characteristics of the JYP0035 capsule in patients with advanced solid tumors. The main questions it aims to answer are: * What is the safety profile of JYP0035 when administered to these patients? * How does JYP0035 capsule behave in the body pharmacokinetically? Participants will: * Receive escalating doses of JYP0035 capsule during the dose-escalation phase (PART-1). * Continue with the identified dose in the dose-expansion phase (PART-2). As this is a single-arm study, there is no comparison group.
Official title: An Open-label Multicenter, Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of JYP0035 Capsule Monotherapy in Patients With Advanced Solid Tumors
Key Details
Gender
All
Age Range
18 Years - 74 Years
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2024-01-01
Completion Date
2027-12-01
Last Updated
2024-11-18
Healthy Volunteers
No
Conditions
Interventions
JYP0035 Experimental Drug Treatment
Single dose intervention
Locations (1)
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China